Evaluation of Lipid Profile, Apo B/ Apo A Ratio and Lpa and its Relationship with Cognitive Disorders in the Older Adults: Birjand Longitudinal Aging Study
Archives of Advances in Biosciences,
Vol. 14 No. 1 (2023),
19 February 2023
,
Page 1-8
https://doi.org/10.22037/aab.v14i1.39857
Abstract
Introduction: Accurate and timely diagnosis of mild cognitive disorders is essential to prevent their progression to dementia. This study aimed to determine the relationship among the serum levels of lipid markers of cognitive disorders in older adults in Birjand.
Materials and Methods: The community-based cohort study was performed on 1400 older adults population (60 years and older) living in urban and rural areas of Birjand, among whom 242 older adults were selected by multi-stage random sampling; the Mini-Mental State Examination Cognitive Disorders Questionnaire was completed, and five cc of blood samples were taken to assess Triglyceride, Cholesterol, Low density lipoprotein, High-density lipoprotein, lipoprotein a, Apo lipoprotein A, and Apo lipoprotein B.
Results: The mean age of participants was 70.6± 6.96 years. 55.4% were women. The level of MMSE was significantly different based on the demographic information. Mean serum levels of Lipid profile, Apo B/ Apo A Ratio, and LP a, were not significantly different from MMSE.
Conclusion: The study showed a significant relationship between demographic information and MMSE level, so it can be used to improve the cognitive level of older adults by changing their life situation, marital status, and education. However, the parameters of Lipid profile, Apo B/ Apo A Ratio, and LP a are not used to diagnose cognitive disorders in older adults.
- Cognitive Disorders
- Lipid Profile
- Lpa
- Apolipoprotein B Apolipoprotein A-I Ratio
How to Cite
References
UN U. Department of economic and social affairs. Population Division; 2017.
Louis ED, Mayer SA. Merritt’s neurology. Lippincott Williams & Wilkins; 2021.
Ahmadi Ahangar A, Saadat P, Hosseini SR, Bijani A, Samaei SE, Mostafazadeh Bora M, et al. Relationship of serum lipid levels and other underlying factors with cognitive impairment in the elderly. Iran J Ageing. 2019; 13(5):534-49. [DOI: 10.32598/SIJA.13.Special-Issue.534]
Liu L, Huang X, Feng L, Wu Y. Internal lipid profile and body lipid profile in relation to cognition: a cross-sectional study in Southern China. Am J Alzheimer Dis Other Demen. 2020; 35:1533317520962660. [DOI: 10.1177/1533317520962660] [PMID]
McWhirter L, Ritchie C, Stone J, Carson A. Functional cognitive disorders: a systematic review. Lancet Psychiatry. 2020; 7(2):191-207. [DOI: 10.1016/S2215-0366(19)30405-5] [PMID]
Song F, Poljak A, Smythe GA, Sachdev P. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev. 2009; 61(2):69-80. [DOI: 10.1016/j.brainresrev.2009.05.003] [PMID]
Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. 2014; 312(23):2551-61. [DOI: 10.1001/jama.2014.13806] [PMID] [PMCID]
Cooper C, Sommerlad A, Lyketsos CG, Livingston G. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis.
Am J Psychiatry. 2015; 172(4):323-34. [DOI: 10.1176/appi.ajp.2014.14070878] [PMID]
Moriarty PM, Varvel SA, Gordts PL, McConnell JP, Tsimikas S. Lipoprotein (a) mass levels increase significantly according to APOE genotype: an analysis of 431 239 patients. Arterioscler Thromb Vasc Biol. 2017; 37(3):580-8. [DOI: 10.1161/ATVBAHA.116.308704] [PMID] [PMCID]
Nandeesha H, Keshri N, Rajappa M, Menon V. Association of hyperglycaemia and hyperlipidaemia with cognitive dysfunction in schizophrenia spectrum disorder. Arch Physiol Biochem. 2020; 129(2):1-8. [DOI: 10.1080/13813455.2020.1839500] [PMID]
Ma C, Yin Z, Zhu P, Luo J, Shi X, Gao X. Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly. Mol Neurodegener. 2017; 12(1):1-9. [DOI: 10.1186/s13024-017-0167-y] [PMID] [PMCID]
Panza F, Frisardi V, Seripa D, P Imbimbo B, Sancarlo D, D'Onofrio G, et al. Metabolic syndrome, mild cognitive impairment and dementia. Curr Alzheimer Res. 2011; 8(5):492-509. [DOI: 10.2174/156720511796391818]
Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002; 59(3):378-84. [DOI: 10.1001/archneur.59.3.378] [PMID]
Zhao N, Liu CC, Qiao W, Bu G. Apolipoprotein
E, receptors, and modulation of Alzheimer’s
disease. Biol Psychiatry. 2018; 83(4):347-57. [DOI: 10.1016/j.biopsych.2017.03.003] [PMID] [PMCID]
De Luca V, Spalletta G, Souza RP, Graff A, Bastos-Rodrigues L, Bicalho MAC. Definition of late onset Alzheimer’s disease and anticipation effect of genome-wide significant risk variants: pilot study of the APOE e4 allele. Neuropsychobiology. 2019; 77(1):8-12. [DOI: 10.1159/000490739]
Moodi M, Firoozabadi MD, Kazemi T, Payab M, Ghaemi K, Miri MR, et al. Birjand longitudinal aging study (BLAS): the objectives, study protocol and design (wave I: baseline data gathering). J Diabetes Metab Disord. 2020; 19(1):551-9. [DOI: 10.1007/s40200-020-00504-5] [PMID] [PMCID]
Chen H, Du Y, Liu S, Ge B, Ji Y, Huang G. Association between serum cholesterol levels and Alzheimer’s disease in China: a case-control study. Int J Food Sci Nutr.
; 70(4):405-11. [DOI: 10.1080/09637486.2018.1508426] [PMID]
Ropper Allan H. Adams and Victor’s principles of neurology. United States: McGraw-Hill Education; 2019.
Lanska DJ. Adams and Victor’s principles
of neurology. JAMA. 2010; 303(13):1311-2. [DOI: 10.1001/jama.2010.396]
Moshtagh M, Salmani F, Moodi M, Miri M, Sharifi F. A perspective on the sense of loneliness and its determinants in Iranian older people. Psychogeriatrics. 2022; 22(2):252-8. [DOI: 10.1111/psyg.12809] [PMID]
Hosseini S, Azadforuz S, Parsian H, Rezaei H, Moaudi S, Bijani A. The relationship between serum copper level with cognitive disorders in elderly. J Babol Univ Med Sci. 2016; 18(10):26-31. [DOI: 10.22088/jbums.18.10.26]
Rait G, Fletcher A, Smeeth L, Brayne C, Stirling S, Nunes M, et al. Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community. Age Ageing. 2005; 34(3):242-8. [DOI: 10.1093/ageing/afi039] [PMID]
Wu MS, Lan TH, Chen CM, Chiu HC, Lan TY. Socio-demographic and health-related factors associated with cognitive impairment in the elderly in Taiwan. BMC public health. 2011; 11(1):1-8. [DOI: 10.1186/1471-2458-11-22] [PMID] [PMCID]
Goswami A, Reddaiah V, Kapoor S, Singh B, Dey A, Dwivedi S. Prevalence and determinants of cognitive impairment in rural elderly population in India. Help Age India Res Dev J. 2006; 12(1):8-15.
Paúl C, Ribeiro O, Santos P. Cognitive impairment in old people living in the community. Arch Gerontol Geriatr. 2010; 51(2):121-4. [DOI: 10.1016/j.archger.2009.09.037] [PMID]
Rodríguez-Sánchez E, Mora-Simón S, Patino-Alonso MC, García-García R, Escribano-Hernández A, García-Ortiz L, et al. Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study. BMC Neurol. 2011; 11(1):1-13. [DOI: 10.1186/1471-2377-11-147] [PMID] [PMCID]
Rashid A, Azizah A, Rohana S. Cognitive impairment among the elderly Malays living in rural Malaysia. Med J Malaysia. 2012; 67(2):186-9. [PMID]
Kim M, Park J, Lee C, Kang N, Ryu J, Jeon B, et al. Prevalence of dementia and its correlates among participants in the national early dementia detection program during 2006-2009. Psychiatry Investig. 2012; 9(2):134-42. [DOI: 10.4306/pi.2012.9.2.134] [PMID] [PMCID]
Zunzunegui MV, Alvarado BE, Béland F, Vissandjee B. Explaining health differences between men and women in later life: a cross-city comparison in Latin America and the Caribbean. Soc Sci Med. 2009; 68(2):235-42. [DOI: 10.1016/j.socscimed.2008.10.031] [PMID]
Shin KR, Jung D, Jo I, Kang Y. Depression among community-dwelling older adults in Korea: a prediction model of depression. Arch Psychiatr Nurs. 2009; 23(1):50-7. [DOI: 10.1016/j.apnu.2008.03.001] [PMID]
Bucci M, Tana C, Giamberardino M, Cipollone F. Lp (a) and cardiovascular risk: investigating the hidden side of the moon. Nutr Metab Cardiovasc Dis. 2016; 26(11):980-6. [DOI: 10.1016/j.numecd.2016.07.004] [PMID]
Liu Y, Zhong X, Shen J, Jiao L, Tong J, Zhao W, et al. Elevated serum TC and LDL-C levels in Alzheimer’s disease and mild cognitive impairment: a meta-analysis study. Brain Res. 2020; 1727:146554. [DOI: 10.1016/j.brainres.2019.146554] [PMID]
Yasuno F, Tanimukai S, Sasaki M, Hidaka S, Ikejima C, Yamashita F, et al. Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype. Am J Geriatr Psychiatry. 2012; 20(7):574-83. [DOI: 10.1097/JGP.0b013e318211819b] [PMID]
Cheng Y, Jin Y, Unverzagt FW, Su L, Yang L, Ma F, et al. The relationship between cholesterol and cognitive function is homocysteine-dependent. Clin Interv Aging. 2014; 9:1823-9. [DOI: 10.2147/CIA.S64766] [PMID] [PMCID]
Andaloro A, Russo M, Pastura C, Sessa E, Calatozzo P, Maggio MG, et al. Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis? Int J Neurosci. 2020; 132(2):1-6. [DOI: 10.1080/00207454.2020.1807980] [PMID]
Wu Y, Wang Z, Jia X, Zhang H, Zhang H, Li J, et al. Prediction of Alzheimer’s disease with serum lipid levels in Asian individuals: a meta-analysis. Biomarkers. 2019; 24(4):341-51. [DOI: 10.1080/1354750X.2019.1571633] [PMID]
Huang Y. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases. Curr Opin Lipidol. 2010; 21(4):337-45. [DOI: 10.1097/MOL.0b013e32833af368] [PMID]
Hottman DA, Chernick D, Cheng S, Wang Z, Li L. HDL and cognition in neurodegenerative disorders. Neurobiol Dis. 2014; 72:22-36. [DOI: 10.1016/j.nbd.2014.07.015] [PMID]
Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, Ladu MJ, et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci. 2009; 29(48):15317-22. [DOI: 10.1523/JNEUROSCI.4026-09.2009] [PMID] [PMCID]
- Abstract Viewed: 309 times
- PDF Downloaded: 178 times